Basit öğe kaydını göster

dc.contributor.authorHacohen, Y.
dc.contributor.authorFilippi, M.
dc.contributor.authorJuuti, R.
dc.contributor.authorHemmer, B.
dc.contributor.authorTintore, M.
dc.contributor.authorOtero-Romero, S.
dc.contributor.authorLebrun-Frenay, C.
dc.contributor.authorReyes, S.
dc.contributor.authorAmato, M. P.
dc.contributor.authorCampins, M.
dc.contributor.authorFarez, M. F.
dc.contributor.authorVukusic, S.
dc.contributor.authorSiva, A.
dc.contributor.authorOreja-Guevara, C.
dc.contributor.authorMelinda, M.
dc.date.accessioned2021-12-10T13:10:44Z
dc.date.available2021-12-10T13:10:44Z
dc.date.issued2021
dc.identifier.citationOtero-Romero S., Lebrun-Frenay C., Reyes S., Amato M. P. , Campins M., Farez M. F. , Filippi M., Hemmer B., Hacohen Y., Juuti R., et al., "ECTRIMS-EAN European consensus on vaccination in patients with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs", MULTIPLE SCLEROSIS JOURNAL, cilt.27, sa.2_SUPPL, ss.744-745, 2021
dc.identifier.issn1352-4585
dc.identifier.othervv_1032021
dc.identifier.otherav_f427eb3f-fa91-401f-a003-f82b61dbcbf7
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175602
dc.language.isoeng
dc.subjectNeurology (clinical)
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectSinirbilim ve Davranış
dc.subjectHuman-Computer Interaction
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSensory Systems
dc.subjectNeuroscience (miscellaneous)
dc.subjectGeneral Neuroscience
dc.subjectCognitive Neuroscience
dc.subjectCellular and Molecular Neuroscience
dc.subjectDevelopmental Neuroscience
dc.subjectNeurology
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectNöroloji
dc.titleECTRIMS-EAN European consensus on vaccination in patients with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs
dc.typeMakale
dc.relation.journalMULTIPLE SCLEROSIS JOURNAL
dc.contributor.departmentAutonomous University of Barcelona , ,
dc.identifier.volume27
dc.identifier.issue2_SUPPL
dc.identifier.startpage744
dc.identifier.endpage745
dc.contributor.firstauthorID2770524


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster